BioElectronics Corporation Announces Development of New Sports Medicine Products5 April 2006
BioElectronics Corporation, (Pink Sheets: BIEL), announced today that the company has developed the next-generation ActiPatch(TM) products for the sports medicine markets. "We are pleased to announce that we have developed an introductory line of new products that are specific to sports medicine with professional sports teams. There are 5 unique designs that are designed to work in conjunction with other therapeutic treatments that the team trainers and physicians provide. The products are very flexible, durable and can be worn continuously which is a big help in keeping players on the field which is the ultimate goal of any sports medicine solution. We are pleased with the new designs and we look forward to continuing our work with sports trainers and physicians," said Thomas J. O'Connor, COO of Bioelectronics Corporation. Ed Suliga of Resource Marketing and the Co-Chair of the company's Sports Training Advisory Council commented, "These new products are very exciting and the ability to deliver this breakthrough therapy in unique shapes and sizes really makes the product very easy to use and durable. We have spent a lot of time working with over 15 professional sports teams in evaluating the product and are very pleased that the teams have adopted these solutions. The Detroit Lions have already stocked up again for their preseason mini-camp." The new ActiPatch(TM) for sports medicine products are available in five unique shapes tailored for specific applications. The products were designed in conjunction with leading sports trainers and orthopedic physicians throughout the country. The same drug-free anti-inflammatory properties remain while the product is much thinner and more flexible in design, enabling ActiPatch to be embedded or used in conjunction with a wide range of therapeutic delivery systems. ActiPatch(TM) is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, patient friendly method to reduce soft tissue pain and swelling. For more information visit http://www.bioelectronicscorp.com Safe Harbor Statement: This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.
Source: prnewswire
All trademarks and copyrighted information contained herein are the property of their respective owners.
Related Articles
|